BIO welcomes EPA proposed rule on new RFS2 pathways.
Share:
Press Release Summary:
BIO welcomed public comment on proposed Renewable Fuel Standard amendments and clarifications, which include new pathway determinations for advanced biofuels such as isobutanol and ethanol from crop residues. Brent Erickson, EVP of BIO's Industrial and Environmental Section, said, "Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident."
Original Press Release:
BIO Welcomes EPA Proposed Rule on New RFS2 Pathways
WASHINGTON--The Biotechnology Industry Organization (BIO) today welcomed the opportunity for public comment on proposed Renewable Fuel Standard (RFS2) amendments and clarifications, which include new pathway determinations for advanced biofuels such as isobutanol and ethanol from crop residues.
“Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident. We look forward to working with EPA to rapidly finalize these new rules.”
Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, said, “We appreciate EPA moving forward as rapidly as possible with these program amendments. Companies continue to make investments, put steel in the ground, create jobs and develop technologies that reduce dependence on foreign oil and contribute to a cleaner environment. They are preparing to make additional investments with assurance that U.S. policy is committed to energy security and production of biofuels.
“Finalization of new pathways will clear the way for companies to bring innovative technologies to the marketplace. Delays can determine whether these companies succeed or fail and whether investors remain confident. We look forward to working with EPA to rapidly finalize these new rules.”
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
World Congress on Industrial Biotechnology
June 16-19, 2013
Montreal, Canada
BIO Investor Forum
October 8-9, 2013
San Francisco, CA
BIO IPCC Conference
November 6-8, 2013
Washington, DC
BIO Convention in China
November 11-13, 2013
Beijing, China
Pacific Rim Summit on Industrial Biotechnology & Bioenergy
December 8-11, 2013
San Diego, CA
BIO CEO & Investor Conference
February 10 – 11, 2014
New York, NY
Contacts
Biotechnology Industry Organization (BIO)
Paul Winters, 202-962-9237
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech